Trexquant Investment LP Atreca, Inc. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $74,097 - $162,395	-25,818 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$4.91 - $9.07 $98,023 - $181,073	-19,964 Reduced 43.61%	25,818 $161,000
Q2 2021 Aug 12, 2021	BUY	$7.82 - $13.8 $358,015 - $631,791	45,782 New	45,782 $390,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.